PLOD2, a key factor for MRL MSC metabolism and chondroprotective properties - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Current Stem Cell Research & Therapy Année : 2024

PLOD2, a key factor for MRL MSC metabolism and chondroprotective properties

Mingxing Wei
  • Fonction : Auteur

Résumé

Abstract Background Initially discovered for its ability to regenerate ear holes, the Murphy Roth Large (MRL) mouse has been the subject of multiple research studies aimed at evaluating its ability to regenerate other body tissues and at deciphering the mechanisms underlying it. These enhanced abilities to regenerate, retained during adulthood, protect the MRL mouse from degenerative diseases such as osteoarthritis (OA). Here, we hypothesized that mesenchymal stromal/stem cells (MSC) derived from the regenerative MRL mouse could be involved in their regenerative potential through the release of pro-regenerative mediators. Method To address this hypothesis, we compared the secretome of MRL and BL6 MSC and identified several candidate molecules expressed at significantly higher levels by MRL MSC than by BL6 MSC. We selected one candidate, Plod2 , and performed functional in vitro assays to evaluate its role on MRL MSC properties including metabolic profile, migration, and chondroprotective effects. To assess its contribution to MRL protection against OA, we used an experimental model for osteoarthritis induced by collagenase (CiOA). Results Among the candidate molecules highly expressed by MRL MSC, we focused our attention on procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 (PLOD2). Plod2 silencing induced a decrease in the glycolytic function of MRL MSC, resulting in the alteration of their migratory and chondroprotective abilities in vitro. In vivo, we showed that Plod2 silencing in MRL MSC significantly impaired their capacity to protect mouse from developing OA. Conclusion Our results demonstrate that the chondroprotective and therapeutic properties of MRL MSC in the CiOA experimental model are in part mediated by PLOD2.

Dates et versions

inserm-04520310 , version 1 (25-03-2024)

Identifiants

Citer

Sarah Bahraoui, Gautier Tejedor, Anne-Laure Mausset-Bonnefont, François Autelitano, Audrey Barthelaix, et al.. PLOD2, a key factor for MRL MSC metabolism and chondroprotective properties. Current Stem Cell Research & Therapy, 2024, 15 (1), pp.70. ⟨10.1186/s13287-024-03650-2⟩. ⟨inserm-04520310⟩
6 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More